As water turns toxic, tunnels flood, and sanitation workers die in sewers, a deeper failure surfaces—absence of underground ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...
Across the United States, one of the country's most storied manufacturers is dangling a six figure paycheck for skilled ...
America’s AI boom is driving a surge in data center construction—along with rising water demand. Why water is becoming the ...
Apogee Therapeutics (APGE) is in focus after releasing interim Phase 1b data for its asthma drug candidate zumilokibart, highlighting robust FeNO biomarker suppression, a clean safety profile, and ...
Discover how the Middle East is set to invest over $100 billion annually by 2026 in sectors like energy, AI, and healthcare, ...
AMD gains AI share as DC revenue hit $4.3B, MI300 adoption rises, MI400 targets cloud inference at premium valuation. Read ...
A fully managed AI Agents Business Portal centralizes lead capture, unified inbox, CRM, automation, and reporting, so ...
New industry report reveals £530 billion infrastructure pipeline driving optimism, while sector faces urgent need for ...
Ameren trades near 20x forward P/E with the lowest yield, strong CAPEX, data center growth, and regulatory risk priced in.
Brokerage estimates point to TCS' modest revenue expansion, stable demand in key verticals and close scrutiny of deal wins, ...